Extract from webinar Question: Microbix may generate incremental capsules of approximately 5 million Canadian related to this agreement, and it's initially fiscal year of 2023. Can you give us an idea of how big this potentially can get beyond 2023? And what would be supporting factors for the contract to get bigger? Is there a chance this contract turns out to be less than 5 million annually in the future? Cameron Groome: I would be shocked if this contract turned out to be less than 5 million. In the future, I expect that certainly its first year achievement will comfortably come in at or above that 5 million number or we would not have cited it in our news release. And I would look for it to grow substantially from there. So I could see this as the different tests that are that are going to into which our QAPs will be an integral part gained traction and success in the marketplace. I would see it rising multiples of that $5 million number over the five year initial term. And ideally, these are forever